Skip to main content
PharmaCielo Ltd. logo

PharmaCielo Ltd. — Investor Relations & Filings

Ticker · PCLO ISIN · CA71716K1012 LEI · 5493002XOFWMT83TYQ57 TSXV Manufacturing
Open in API
Filings indexed 389 across all filing types
Latest filing 2022-10-13 Audit Report / Informat…
Country CA Canada
Listing TSXV PCLO

About PharmaCielo Ltd.

https://www.pharmacielo.com/

PharmaCielo Ltd. is a global supplier specializing in the cultivation, processing, and distribution of medicinal-grade cannabis extracts and dried flower. The company focuses on ethical and sustainable production, aiming to be a leading partner in the global medicinal cannabis market. Utilizing ideal equatorial conditions, PharmaCielo operates large-scale, high-efficiency production facilities, including 12 hectares of open-air greenhouses, enabling four full crops annually for reliable supply. Its product portfolio includes standardized extracts, such as high-purity CBD Isolate, and both psychoactive and non-psychoactive derivatives. Production adheres to pharmaceutical-quality standards, supported by proprietary genetics maintained in a tissue culture lab and advanced processing facilities ensuring consistency and safety.

Recent filings

Filing Released Lang Actions
Notice.pdf
Audit Report / Information Classification · 95% confidence The document is a notice of change of auditor addressed to multiple securities commissions and the predecessor and successor auditors. It details the resignation of the previous auditor and appointment of the new auditor, with references to regulatory compliance under NI 51-102. The document is short (1362 characters) and serves as an announcement rather than containing any audit report or financial statements. It does not contain an audit report itself, nor detailed financial data or analysis. Therefore, it fits best under the category of Audit Report / Information (AR) as it relates specifically to auditor changes and audit-related disclosures, but since it is a notice and not a full audit report, the closest appropriate category is AR rather than a full Annual Report or Regulatory Filing. Confidence is high due to clear auditor change notice and regulatory references. FY 2022
2022-10-13 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the shipment of pharmaceutical grade cannabis extract to a customer in Uruguay. It includes management commentary and forward-looking statements but does not contain any financial statements, detailed financial data, or regulatory filings. The document is relatively short (4566 characters) and serves as a business update rather than a formal financial report or regulatory filing. It does not announce voting results, changes in management, or capital structure changes. It is not a transcript, audit report, or earnings release. The content fits best as a general regulatory announcement or business update. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-10-12 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing PharmaCielo's first shipment of medicinal grade dried cannabis flower to the Czech Republic, highlighting business development progress and market expansion. It contains no financial statements, regulatory filings, or detailed financial data. It is a corporate announcement about a business milestone rather than a financial report, management change, or regulatory filing. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and corporate news that does not fit other specific categories.
2022-09-15 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that PharmaCielo has received a production quota for THC dominant dried cannabis flower for export and plans to begin shipments in early 2023. It includes management commentary, company background, and forward-looking statements. There are no financial statements, detailed financial performance data, or regulatory filing references. The content is an update on company operations and future plans rather than a formal financial report or regulatory filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Capital Update. It is a general corporate announcement about production and export quota receipt, which aligns best with Regulatory Filings (RNS) as a general announcement category for miscellaneous filings that do not fit other specific categories.
2022-09-14 English
News release - English.pdf
Regulatory Filings
2022-08-30 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2022-08-30 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.